Ionis Pharmaceuticals | IONS - Assets


Ionis Pharmaceuticals reported $3.45B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Agios Pharmaceuticals USD 1.18B 112.24M Mar/2026
Alnylam Pharmaceuticals USD 5.13B 163.22M Mar/2026
Arrowhead Research USD 2.27B 664.08M Mar/2026
Astellas Pharma JPY 3.57T 36.87B Mar/2026
BioCryst Pharmaceuticals USD 465.05M 49.11M Mar/2026
BioMarin Pharmaceutical USD 8.59B 996.99M Mar/2026
Celltrion KRW 768.81B 9.37B Mar/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Exelixis USD 2.59B 250.83M Mar/2026
Halozyme Therapeutics USD 2.67B 147.4M Mar/2026
Ionis Pharmaceuticals USD 3.45B 74M Mar/2026
Kangmei Pharma CNY 13.31B 375.64M Mar/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Moderna USD 11.49B 850M Mar/2026
Nektar Therapeutics USD 280.41M 20.94M Dec/2025
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Neurocrine Biosciences USD 4.91B 274.7M Mar/2026
Novartis USD 118.53B 7.58B Mar/2026
Omeros USD 200.57M 34.59M Jun/2025
OPKO Health USD 1.86B 75.15M Mar/2026
Organigram Holdings CAD 521.31M 9.36M Mar/2026
Ovoca Bio EUR 1.66M 9.75M Jun/2025
Pfizer USD 207.62B 542M Mar/2026
Pharma Mar EUR 385.26M 9.82M Mar/2026
PTC Therapeutics USD 2.87B 29.66M Mar/2026
Qiagen NV USD 6.3B 257.54M Dec/2025
Regeneron Pharmaceuticals USD 40.87B 310.1M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Sarepta Therapeutics USD 3.18B 170.77M Mar/2026
Sartorius EUR 9.87B 154.9M Mar/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Tilray USD 2.1B 15.95M Sep/2025
Ultragenyx Pharmaceutical USD 1.3B 236M Mar/2026
Vertex Pharmaceuticals USD 26.48B 841.4M Mar/2026
Zealand Pharma A/S 15.95B 848.45M Dec/2025
Zz Pientze Pharmaceu CNY 18.38B 905.93M Mar/2026